Colon Cancer Stage I Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Colon Cancer Stage I clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2Phase 3

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Colon Cancer Stage III
Chungnam National University Hospital308 enrolled1 locationNCT05179889
Recruiting
Not Applicable

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Liver CancerBiliary Tract CancerColon Cancer+76 more
Cedars-Sinai Medical Center360 enrolled1 locationNCT04907643
Recruiting
Phase 2

Phase II Study of Neoadjuvant Dostarlimab in Patients With Untreated T3-4N0-2 or Stage III pMMR/MSS Resectable Colon Cancer

Colon Cancer Stage III
Universitaire Ziekenhuizen KU Leuven10 enrolled1 locationNCT06830239
Recruiting
Phase 1

A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

Colon Cancer Stage I
Medigen Biotechnology Corporation18 enrolled1 locationNCT05394714
Recruiting
Phase 3

The Sagittarius Trial

Colon Cancer Stage IIIColon Cancer Stage II
IFOM ETS - The AIRC Institute of Molecular Oncology700 enrolled26 locationsNCT06490536
Recruiting
Not Applicable

Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

Circulating Tumor DNARecurrenceColon Cancer Stage II
UMC Utrecht1,320 enrolled29 locationsNCT06434896
Recruiting
Phase 3

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

Colon Cancer Stage IIIColon Cancer Stage II
Sun Yat-sen University840 enrolled1 locationNCT05194878
Recruiting
Phase 3

Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

Colon Cancer Stage II
Technische Universität Dresden4,812 enrolled1 locationNCT04089631